Clinical TrialChronic PainKetamineKetamineKetamineKetamineRecruiting

Ketamine Treatment Plans for Chronic Conditions

Observational cohort study (n=500) evaluating real-world home and clinic ketamine treatment plans for people with chronic conditions (pain, depressive and anxiety disorders) and the effect of adjunct therapies.

Target Enrollment
500 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

This observational cohort (cross-sectional elements) will characterise how ketamine is prescribed and delivered off-label across chronic conditions, including routes (IV, IM, SubQ, sublingual and others), dosing patterns, and concurrent treatments.

The study will document adjunct modalities (psychotherapy, music therapy, acutherapy) and examine associations between adjunct use and clinical outcomes for pain, mood and anxiety.

A secondary focus is the relationship between ketamine treatment and suicidal ideation among participants with chronic conditions.

Study Protocol

Preparation

sessions

Dosing

sessions

Integration

sessions

Therapeutic Protocol

Manualized psychotherapy included

Study Arms & Interventions

Chronic Pain

experimental

The use of ketamine in chronic pain

Interventions

  • Ketamine
    via Other• variable

    IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.

Depressive Disorders

experimental

The use of ketamine in depressive disorders

Interventions

  • Ketamine
    via Other• variable

    IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.

Anxiety Disorders

experimental

The use of ketamine in anxiety disorders

Interventions

  • Ketamine
    via Other• variable

    IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.

Chronic Conditions

experimental

The use of ketamine in chronic conditions

Interventions

  • Ketamine
    via Other• variable

    IV/IM/SubQ/Sublingual and other routes used per clinician; dosing per treating clinician.

Participants

Ages
18 – 99
Sexes
Male & Female

Inclusion Criteria

  • Inclusion Criteria:
  • Must have an identifiable chronic condition.

Exclusion Criteria

  • Exclusion Criteria:
  • Healthy population

Study Details

Locations

RIVER Telehealth — Helena, Montana, United States

Your Library